Citation Impact
Citing Papers
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Downregulation of Plk1 Expression By Receptor-Mediated Uptake of Antisense Oligonucleotide-Loaded Nanoparticles
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
1999
Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour
2015
The DNA-damage response in human biology and disease
2009 StandoutNature
Does a targeting ligand influence nanoparticle tumor localization or uptake?
2008
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Engineering Liposomes and Nanoparticles for Biological Targeting
2010
DNA-based asymmetric catalysis
2010 StandoutNobel
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
Clinical translation of angiogenesis inhibitors
2002 Standout
Solid supported lipid bilayers: From biophysical studies to sensor design
2006
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Lipid-based vectors for siRNA delivery
2012
Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin
2007
Telomere states and cell fates
2000 StandoutNatureNobel
Evolution and clinical translation of drug delivery nanomaterials
2017
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
2009
DNA-based therapeutics and DNA delivery systems: A comprehensive review
2005
Molecular Transporters: Synthesis of Oligoguanidinium Transporters and Their Application to Drug Delivery and Real‐Time Imaging
2006
Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy
2007
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
2002
The biology of VEGF and its receptors
2003 Standout
Analyzing real-time PCR data by the comparative CT method
2008 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Biocompatibility, Biodistribution, and Drug‐Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals
2010
Lipid-based Nanoparticles for Nucleic Acid Delivery
2007
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
2013
High‐resolution light microscopy using luminescent nanoparticles
2010
Classification of anticancer drugs—a new system based on therapeutic targets
2003
Switching and Signaling at the Telomere
2001 StandoutNobel
Engineering RNA for Targeted siRNA Delivery and Medical Application
2010
Wavelength‐Selective Light‐Induced Release from Plasmon Resonant Liposomes
2011
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
2007
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Drug Targeting to Cancer by Nanoparticles Surface Functionalized with Special Biomolecules
2012
Breast Cancers: MR Imaging of Folate-Receptor Expression with the Folate-Specific Nanoparticle P1133
2010
Tumor-targeted gene transfer with DNA polyplexes.
2002
Ligand-directed targeting of genes to the site of disease
2003
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Human Endothelial Cell Life Extension by Telomerase Expression
1999
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
2009
The Golden Age of Transfer Hydrogenation
2015 Standout
Control of the Molecular Orientation of Membrane-Anchored Biomimetic Glycopolymers
2009 StandoutNobel
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Transferrin receptor 1 in cancer: a new sight for cancer therapy.
2018
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters
2000
State of the Art and Prospects in Metal–Organic Framework (MOF)-Based and MOF-Derived Nanocatalysis
2019 Standout
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Nonviral Vectors for Gene Delivery
2008 Standout
Potential of Advexin ® : A p53 Gene-Replacement Therapy in Li–Fraumeni Syndrome
2008
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Delivery of Small Interfering RNA by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid Bilayers
2012
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
DNA origami protection and molecular interfacing through engineered sequence-defined peptoids
2020 StandoutNobel
A Systematic Analysis of Peptide Linker Length and Liposomal Polyethylene Glycol Coating on Cellular Uptake of Peptide-Targeted Liposomes
2013
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Angiogenesis
2006
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation
2001 StandoutNobel
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
2006 StandoutScience
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Single-Molecule Motions of Oligoarginine Transporter Conjugates on the Plasma Membrane of Chinese Hamster Ovary Cells
2008 StandoutNobel
Nanooncology: The future of cancer diagnosis and therapy
2013
Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery
2003
Clinical Translation of Nanomedicine
2015
Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine
2011 StandoutNobel
Works of Antonina Rait being referenced
Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System
2007
Chemically Modified Short Interfering Hybrids (siHYBRIDS): Nanoimmunoliposome DeliveryIn VitroandIn Vivofor RNAi of HER-2
2006
Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer
2001
HER‐2‐Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents
2003
Restoration of the G1 Checkpoint and the Apoptotic Pathway Mediated by Wild-type p53 Sensitizes Squamous Cell Carcinoma of the Head and Neck to Radiotherapy
1997
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy
2013
A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene
2004
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
2013 Nobel
Antisense therapeutics: from theory to clinical practice
2003
Evidence Supporting a Signal Transduction Pathway Leading to the Radiation-Resistant Phenotype in Human Tumor Cells
1997
Downmodulation of bFGF-binding protein expression following restoration of p53 function
2001
Transferrin-Liposome-Mediated Systemic p53 Gene Therapy in Combination with Radiation Results in Regression of Human Head and Neck Cancer Xenografts
1999
Tumor-Targeting Nanoimmunoliposome Complex for Short Interfering RNA Delivery
2006
Self-Assembly of a Virus-Mimicking Nanostructure System for Efficient Tumor-Targeted Gene Delivery
2002
Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue
2008
Tumor-Targeting Nanocomplex Delivery of Novel Tumor Suppressor RB94 Chemosensitizes Bladder Carcinoma CellsIn vitroandIn vivo
2008
Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
2002
Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment.
2004
Antisense oligonucleotides targeted to the human α folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment
2004
Systemic p53 Gene Therapy of Cancer with Immunolipoplexes Targeted by Anti-Transferrin Receptor scFv
2001
3‘-End Conjugates of Minimally Phosphorothioate-Protected Oligonucleotides with 1-O-Hexadecylglycerol: Synthesis and Anti-ras Activity in Radiation-Resistant Cells
2000